Electromed shares rose after the medical-equipment maker posted quarterly earnings ahead of market expectations.
Shares of the maker of airway-clearance devices rose 7.2% to $17.21 in after-hours trading, after closing Tuesday’s regular session up 6.9% at 16.05.
The New Prague, Minn., company said its fiscal fourth-quarter net income was $1.8 million, or 20 cents a share, up from $1 million, or 12 cents a share a year earlier. Analysts polled by FactSet had forecast EPS of 14 cents.
In a news release, Chief Executive Jim Cunniff said Electromed gained market share thanks to infrastructure investments across its commercial team, and to raising awareness of its high-frequency chest wall oscillation therapy. This HFCWO therapy is for people with bronchiectasis, a condition that causes widened airways in the lungs, making them more vulnerable to infection.